Healthy Clinical Trial
Official title:
Genetic and Environmental Factors in the Response to Influenza Vaccination
The purpose of the study is to investigate and compare the immune responses to influenza vaccination in monozygotic (identical) and dizygotic (fraternal) twins to determine the roles of genetics and environment in the response to flu vaccination.
This is a phase 1 study of 120 healthy 12-49 year old adolescents and adult volunteers who
are given licensed seasonal influenza vaccine. There are no exclusions for gender, ethnicity
or race. The volunteers will be enrolled into one of 3 groups:
Group A: Up to 40 healthy monozygotic (MZ) twin volunteers, 12-49 years old, will be given
inactivated influenza vaccine quadrivalent (IIV4). Each volunteer will complete a total of 3
visits: Day 0 (pre-immunization), Day 6-8 and Day 28+ 7 post-immunization. All visits will
consist of drawing blood for study assays and monitoring for serious adverse events (SAEs).
Group B: Up to 40 healthy dizygotic (DZ) twin volunteers, 12-49 years old, will be given
inactivated influenza vaccine quadrivalent (IIV4). Each volunteer will complete a total of 3
visits: Day 0 (pre-immunization), Day 6-8 and Day 28+7 post-immunization. All visits will
consist of drawing blood for study assays and monitoring for serious adverse events (SAEs).
Group C: Up to 40 healthy monozygotic (MZ) twin volunteers, 12-49 years old, will be
randomized within the twin pair to receive either inactivated influenza vaccine quadrivalent
(IIV4) or live, attenuated influenza vaccine quadrivalent (LAIV4). Each volunteer will
complete a total of 3 visits: Day 0 (pre-immunization), Day 6-8 and Day 28+7
post-immunization. All visits will consist of drawing blood for study assays and monitoring
for serious adverse events (SAEs). This group was terminated in 2016 due to ACIP
recommendations against the use of LAIV but was reopened in 2018 with the availability of
LAIV4.
Each twin is counted as a single participant. All reporting numbers reflect the number of
participants, not the number of twin pairs.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |